Skip to content

Clinical trials

Phase 3 Lymphoma, Large-Cell, Anaplastic trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, Large-Cell, Anaplastic Phase: Phase 3 Clear all

30 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20003
20012
20021
20033
20052
20062
20072
20082
20091
20101
20131
20211
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed23
Unknown status3
Recruiting2
Active, not recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
German High-Grade Non-Hodgkin's Lymphoma Study Group3
Jonsson Comprehensive Cancer Center3
Alliance for Clinical Trials in Oncology2
Memorial Sloan Kettering Cancer Center2
NCIC Clinical Trials Group2
Cancer Research Campaign Clinical Trials Centre1
Case Comprehensive Cancer Center1
Children's Cancer Group, China1
Children's Oncology Group1
Clatterbridge Centre for Oncology1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, Large-Cell, Anaplastic30
Lymphoma, Large B-Cell, Diffuse23
Lymphoma22
Lymphoma, Non-Hodgkin22
Lymphoma, Mantle-Cell21
Burkitt Lymphoma20
Lymphoma, B-Cell, Marginal Zone20
Lymphoma, Follicular20
Lymphoma, Large-Cell, Immunoblastic20
Immunoblastic Lymphadenopathy19

Trials

Showing 51 to 30 of 30. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.